School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Department of Health and Human Development, University of Pittsburgh, Pittsburgh Pennsylvania, USA.
Sleep Health. 2021 Apr;7(2):161-167. doi: 10.1016/j.sleh.2020.12.004. Epub 2021 Jan 2.
Snoring is often used as a surrogate measure for obstructive sleep apnea (OSA), a sleep disorder associated with cardiovascular disease (CVD) risk. Whether snoring is linked to CVD independent of OSA remains unclear. We aimed to explore the snoring and subclinical CVD association in adults with and without OSA.
We conducted a cross-sectional study in 122 overweight/obese participants (24% male; mean age 40.1 years) attending the 24-month follow-up visit of a lifestyle intervention. Using home-based objective measures of sleep-disordered breathing, we stratified participants into 3 snoring/OSA categories using the snoring index (SI), a measure of snoring vibration, and oxygen desaturation index (ODI): (1) OSA (ODI ≥ 5), (2) non-OSA heavy snorer (ODI <5, above-median SI), and (3) non-OSA low snorer (ODI <5, below-median SI). Vascular measures including pulse wave velocity ([PWV]; carotid-femoral [cf], femoral-ankle [fa], brachial-ankle [ba]), carotid intima-media thickness (IMT), and carotid interadventitial diameter (IAD) were compared across snoring/OSA categories. Linear regressions assessed the association between snoring and subclinical CVD independent of traditional CVD risk factors.
Compared to non-OSA low snorers, common carotid IMT and IAD were higher in non-OSA heavy snorers, and faPWV, IMT, and IAD were higher among those with OSA. The difference between non-OSA heavy snorers and low snorers persisted after adjusting for age, race, sex, blood pressure, body mass index, lipids, and insulin resistance (P < .05 for IMT and IAD).
In overweight/obese young to middle-aged adults, objectively measured snoring was related to vascular remodeling in those without OSA. Snoring may contribute to CVD risk but warrants further examination in larger prospective cohorts.
打鼾常被用作阻塞性睡眠呼吸暂停(OSA)的替代指标,OSA 是一种与心血管疾病(CVD)风险相关的睡眠障碍。然而,打鼾是否与 OSA 无关的 CVD 有关尚不清楚。我们旨在探讨患有和不患有 OSA 的成年人中打鼾与亚临床 CVD 的关联。
我们对参加生活方式干预 24 个月随访的 122 名超重/肥胖参与者(24%为男性;平均年龄 40.1 岁)进行了一项横断面研究。使用基于家庭的睡眠呼吸障碍客观测量方法,我们根据打鼾指数(SI)将参与者分为 3 个打鼾/OSA 类别,SI 是衡量打鼾振动的指标,以及氧减饱和指数(ODI):(1)OSA(ODI≥5),(2)非 OSA 重度打鼾者(ODI<5,SI 高于中位数),和(3)非 OSA 轻度打鼾者(ODI<5,SI 低于中位数)。血管指标包括脉搏波速度([PWV];颈股[cf]、股踝[fa]、臂踝[ba])、颈动脉内膜中层厚度(IMT)和颈动脉内中膜直径(IAD)在打鼾/OSA 类别之间进行比较。线性回归评估了打鼾与亚临床 CVD 之间的关联,这种关联独立于传统 CVD 风险因素。
与非 OSA 轻度打鼾者相比,非 OSA 重度打鼾者的颈总动脉 IMT 和 IAD 较高,而 OSA 患者的 faPWV、IMT 和 IAD 较高。在调整年龄、种族、性别、血压、体重指数、血脂和胰岛素抵抗后,非 OSA 重度打鼾者和轻度打鼾者之间的差异仍然存在(IMT 和 IAD 的 P<0.05)。
在超重/肥胖的年轻到中年成年人中,客观测量的打鼾与无 OSA 者的血管重塑有关。打鼾可能会导致 CVD 风险,但需要在更大的前瞻性队列中进一步研究。